![Pierre Vandepapeliere](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Vandepapeliere
Chief Executive Officer at
Amyl Therapeutics SRL
Profile
Pierre Vandepapeliere is the founder of Amyl Therapeutics SRL, serving as Chief Executive & Medical Officer since 2020.
Former positions include Director-Clinical Research at GlaxoSmithKline Biologicals SA, Chief Medical Officer at Neovacs SA, Principal at AstraZeneca, Inc. in 1990, Chief Medical Officer at ImCyse SA in 2019, and Chief Medical Officer & VP-Clinical Development at Abivax SA. Education includes a doctorate from Ghent University and both undergraduate and doctorate degrees from Facultés Universitaires Notre-Dame de la Paix.
Pierre Vandepapeliere active positions
| Companies | Position | Start |
|---|---|---|
Amyl Therapeutics SRL
 Amyl Therapeutics SRL BiotechnologyHealth Technology Operates as a preclinical biotechnology company | Chief Executive Officer | 2019-12-31 |
Former positions of Pierre Vandepapeliere
| Companies | Position | End |
|---|---|---|
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Chief Executive Officer | 2019-08-06 |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Corporate Officer/Principal | 1990-12-30 |
| ABIVAX | Chief Tech/Sci/R&D Officer | - |
GlaxoSmithKline Biologicals SA
 GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Chief Tech/Sci/R&D Officer | - |
| NEOVACS | Chief Tech/Sci/R&D Officer | - |
Training of Pierre Vandepapeliere
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Health Technology |
Neovacs SA
 Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Facultés Universitaires Notre-Dame de la Paix
 Facultés Universitaires Notre-Dame de la Paix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Health Technology |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Operates as a preclinical biotechnology company | Health Technology |
- Stock Market
- Insiders
- Pierre Vandepapeliere
